Mats Jerkeman Selected Research

Mats Jerkeman Research Topics

Disease

42	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 05/2024 - 01/2008
25	Lymphoma (Lymphomas) 04/2024 - 02/2003
24	Neoplasms (Cancer) 04/2024 - 02/2003
21	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 02/2003
7	B-Cell Lymphoma (Lymphoma, B Cell) 04/2024 - 06/2010
5	Disease Progression 01/2023 - 03/2006
5	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021 - 04/2005
4	Residual Neoplasm 12/2023 - 03/2017
3	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2023 - 09/2010
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 07/2010
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019 - 02/2011
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2017 - 09/2010
1	Infections 05/2024
1	Inflammation (Inflammations) 04/2024
1	Epstein-Barr Virus Infections 12/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2022
1	Aphasia (Dysphasia) 01/2021
1	Virus Diseases (Viral Diseases) 01/2019
1	Communicable Diseases (Infectious Diseases) 10/2016
1	Castleman Disease (Castleman's Disease) 05/2016
1	Genetic Translocation (Chromosomal Translocation) 04/2015
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2015
1	Enteropathy-Associated T-Cell Lymphoma 09/2014
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2014
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 06/2014
1	Pathologic Complete Response 05/2014

Drug/Important Bio-Agent (IBA)

20	Rituximab (Mabthera)FDA Link 12/2023 - 09/2009
14	Proteins (Proteins, Gene)FDA Link 04/2024 - 11/2007
9	Cytarabine (Cytosar-U)FDA LinkGeneric 03/2022 - 05/2014
8	ibrutinibIBA 05/2024 - 02/2016
6	Prednisone (Sone)FDA LinkGeneric 01/2018 - 02/2003
6	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 02/2003
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 02/2003
5	Lenalidomide (CC 5013)FDA Link 12/2023 - 10/2016
5	Biomarkers (Surrogate Marker)IBA 07/2023 - 12/2009
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 02/2003
4	Agammaglobulinaemia Tyrosine KinaseIBA 10/2023 - 01/2019
4	Bendamustine Hydrochloride FDA Link 01/2022 - 10/2016
4	Etoposide (VP 16)FDA LinkGeneric 06/2017 - 05/2014
4	Messenger RNA (mRNA)IBA 01/2015 - 01/2008
3	Chimeric Antigen ReceptorsIBA 12/2023 - 01/2019
3	AnthracyclinesIBA 11/2016 - 08/2007
2	Blood Proteins (Serum Proteins)IBA 04/2024 - 06/2014
2	Transcription Factors (Transcription Factor)IBA 08/2023 - 06/2010
2	Circular RNAIBA 04/2022 - 01/2022
2	thiamine triphosphorate (TTP)IBA 01/2022 - 01/2021
2	antineoplaston A10 (A 10)IBA 01/2021 - 09/2010
2	Vitamin D FDA LinkGeneric 01/2021 - 10/2016
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2018 - 01/2015
2	Histone Deacetylase InhibitorsIBA 01/2018 - 01/2015
2	temsirolimus FDA Link 12/2017 - 02/2016
2	Anaplastic Lymphoma KinaseIBA 01/2017 - 09/2014
2	Methotrexate (Mexate)FDA LinkGeneric 11/2016 - 02/2003
2	Melphalan (Alkeran)FDA LinkGeneric 05/2016 - 05/2014
2	Cyclin D1IBA 04/2015 - 01/2008
2	OligonucleotidesIBA 09/2012 - 05/2008
2	SOXC Transcription FactorsIBA 06/2012 - 01/2008
2	Protein Kinase C betaIBA 05/2010 - 11/2007
1	Circulating Tumor DNAIBA 04/2024
1	venetoclaxIBA 12/2023
1	brexucabtagene autoleucelIBA 10/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Immune Checkpoint InhibitorsIBA 12/2022
1	Indicators and Reagents (Reagents)IBA 11/2022
1	triphosphoric acid (triphosphate)IBA 03/2022
1	idelalisibIBA 01/2022
1	Antigen Receptors (Antigen Receptor)IBA 01/2022
1	Complement C4 (Complement Component 4)IBA 01/2022
1	ProteomeIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Formaldehyde (Formol)FDA Link 11/2021
1	SugarsIBA 01/2021
1	tetrapeptide carbamateIBA 01/2021
1	Hormones (Hormone)IBA 01/2019
1	Inotuzumab OzogamicinIBA 01/2018
1	Receptor Tyrosine Kinase-like Orphan ReceptorsIBA 11/2017
1	tocilizumab (atlizumab)FDA Link 05/2016
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 05/2016
1	MicroRNAs (MicroRNA)IBA 04/2015
1	AntibodiesIBA 04/2015
1	ibritumomab tiuxetan (Zevalin)FDA Link 05/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2012
1	IntegrinsIBA 09/2012
1	Peptide Hydrolases (Proteases)FDA Link 09/2012
1	BiglycanIBA 09/2012
1	Proteoglycans (Proteoglycan)IBA 09/2012
1	CollagenIBA 09/2012

Therapy/Procedure

27	Therapeutics 12/2023 - 03/2006
18	Drug Therapy (Chemotherapy) 01/2023 - 03/2006
12	Stem Cell Transplantation 05/2024 - 09/2009
3	Cell Transplantation 12/2021 - 01/2021
2	Radiotherapy 01/2023 - 03/2006
2	Combination Drug Therapy (Combination Chemotherapy) 01/2018 - 05/2016
1	Aftercare (After-Treatment) 12/2023
1	Salvage Therapy 12/2023
1	Precision Medicine 09/2022
1	Immunotherapy 01/2022
1	Transplantation 01/2021
1	Autologous Transplantation 01/2020
1	Mediterranean Diet 01/2019